Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2F. Hoffmann-La Roche

02 1Genentech

03 8Gilead Sciences

04 1Immunomedics

05 1Roche Diagnostics GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Satralizumab

Brand Name : Enspryng

Dosage Form : Solution For Injection

Dosage Strength : 120mg

Packaging :

Approval Date : 24/06/2021

Application Number : 20190821000038

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Satralizumab

Brand Name : Enspryng

Dosage Form : Solution For Injection

Dosage Strength : 120mg/ml

Packaging :

Approval Date : 13/07/2020

Application Number : 67617

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

SATRALIZUMAB

Brand Name : ENSPRYNG

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG/ML

Packaging :

Approval Date :

Application Number : 761149

Regulatory Info :

Registration Country : USA

blank

04

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab Govitecan

Brand Name : TRODELVY

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 180mg

Packaging :

Approval Date : 09/09/2021

Application Number : 68179

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumabgovitekan

Brand Name : Trodelvy

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 200mg

Packaging :

Approval Date : 22/11/2021

Application Number : 20210305000023

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

SACITUZUMAB GOVITECAN

Brand Name : TRODELVY

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 180MG/VIAL

Packaging :

Approval Date :

Application Number : 2520788

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab govitecan

Brand Name : Trodelvy

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab govitecan

Brand Name : Trodelvy

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab govitecan

Brand Name : Trodelvy

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab govitecan

Brand Name : Trodelvy

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Sacituzumab Govitecan

Brand Name : Trodelvy

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 200MG

Packaging :

Approval Date : 2021-11-26

Application Number : 1211592001

Regulatory Info : Authorized

Registration Country : Spain

blank

12

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

SACITUZUMAB GOVITECAN-HZIY

Brand Name : TRODELVY

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 180MG

Packaging :

Approval Date :

Application Number : 761115

Regulatory Info :

Registration Country : USA

blank

13

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Satralizumab

Brand Name : Enspryng

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 120MG

Packaging :

Approval Date : 2021-07-26

Application Number : 1211559001

Regulatory Info : Authorized

Registration Country : Spain

blank